News
The Breas Z2 Auto is a good option for travelers who value simplicity. The machine comes with a bunch of accessories right in ...
Home CPAP device maker Resmed is launching a small, disposable wearable to help diagnose cases of obstructive sleep apnea. | ...
SAN DIEGO – Resmed has announced that its home sleep apnea test, NightOwl, is now available across the U.S.
A big reason for Resmed’s recently announced rebrand is to reflect its increased direct-to-consumer engagement on obstructive ...
Resmed (RMD) announced the publication of a meta-analysis in The Lancet Respiratory Medicine, demonstrating that CPAP therapy significantly reduces the risk of death for people with obstructive ...
NightOwl is now widely available across the United States. Individuals interested in NightOwl should speak with their healthcare provider for more information. To learn more, visit: https://www.resmed ...
Hosted on MSN10mon
Here's How Much a $1000 Investment in ResMed Made 10 Years Ago Would Be Worth TodayResMed's Business In-Depth With that in mind ... During fiscal year 2017, AirMini, the smallest portable CPAP on the market was launched. The company also acquired a line of Chinese-developed ...
CPAP therapy lowered the overall chance of dying by 37% and the chance of heart-related death by 55%.SAN DIEGO, March 19, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the global leader ...
This review included 30 studies to analyze the potential for prolonged life in patients who use CPAP to treat obstructive sleep apnea.
Analysts, including those from Needham and Oppenheimer, flagged risks that Medicare coverage and increasing adoption of GLP-1 therapies could reduce demand for ResMed’s core CPAP devices over time.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results